Whova competitors

Mr. Richer holds full daily operational and P&L responsibility for immixGroup and continues to drive the company forward by evolving the business model and services which help clients maximize their growth potential. An accomplished sales and business development executive who has spent more than 25 years selling information technology products and services within the government sector, Mr. Richer has extensive experience working with technology manufacturers of all sizes, ranging very large and established companies to numerous high growth and emerging technology firms. Armed with strong government sales and business development experience, he has helped technology companies grow their government businesses through cohesive sales, channel, marketing, and business development strategies. Mr. Richer earned a B.S. in Computer Science from the State University of New York Institute of Technology at Utica/Rome.

My career has involved operational, transactional, principal investment, and advisory roles with healthcare and technology companies. I am an active investor and I get involved materially with portfolio companies pre and post investment. I currently serve as a General Partner at Hawthorne Capital Management, Inc. and am currently a Board Director & Executive Chairman at Izenda, Inc., ChartRequest, and CleanData, LLC. I'm currently an Advisor to Blueprint Health, LLC and is also the Founder & Co-Chair of the Atlanta Health 2.0 Chapter. I previously supported the Board/Management of Accelarad, Inc. (acquired by Nuance Communications, Inc. (NASDAQ:NUAN)) of CardioMEMS (acquired by St. Jude Medical (NYSE:STJ)), Fidelis SeniorCare (acquired by Centene (NYSE: CNC), Prenova (acquired by Ecova), and Navini Networks (acquired by Cisco Systems (NASDAQ:CSCO)). I was the Founder & Chief Executive Officer of WisePatient (acquired by Sharecare, Inc. in 2012), a SaaS-based patient access & care coordination platform connecting patients and providers online. Before founding WisePatient, I was a Senior Associate at Merrick Ventures, a healthcare and information technology focused venture capital firm led by Michael Ferro in Chicago, IL. While at Merrick Ventures, I supported the corporate development function of Merge Healthcare (NASDAQ:MRGE acquired by NASDAQ:IBM) focusing on mergers & acquisitions and post-merger integration. Prior to joining Merrick Ventures, I was an Associate at Arcapita Ventures, the growth stage venture capital arm of Arcapita, Inc., evaluating healthcare and information technology related investment opportunities. Prior to Arcapita, I worked in Accenture’s Health and Life Sciences Strategy Practice where he specialized in operational and information technology strategy for integrated delivery networks, academic medical centers, and health plans.

Mark Logan serves as LogRhythm’s Chief Executive Officer. With over 25 years of industry experience in enterprise software, Mr. Logan brings a track record of operational excellence to LogRhythm. His professional accomplishments include leading both Rivermine and Emptoris through their exits, with IBM purchasing the latter for over $500 million. Prior to joining LogRhythm, Mr. Logan was president of Attunity (formerly NASDAQ: ATTU), a leading provider of data integration and big data management software solutions and a division of Qlik. He also previously served in executive roles as CEO of WealthEngine, CEO of Rivermine, and COO of Emptoris. Mr. Logan began his career holding a variety of positions at Hewlett Packard, JD Edwards, and Peoplesoft. He has a B.S. degree in Engineering and Business Management from Providence College.